ArticleTranslational lung cancer research2025

Metachronous development of L858R and T790M EGFR mutations following ALK inhibitor therapy in stage IV lung adenocarcinoma: a case report.

So-Yun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.